Among them, eight were significantly associated with prognosis including RNF212 and ZFR2. Notably, in both the cervical cancer cohort investigated in34 and our vulvar cohort, these two genes exhibited elevated expression in HPV-positive samples. This evidence concerns the gene ZFR2 and cervical carcinoma.